Transaction · 0000200406-26-000179

Schmid Timothy

Schmid Timothy, EVP, CHAIR, reported an open-market or private sale at JOHNSON & JOHNSON involving 22527.000000 shares for an estimated $6189067.98. Reported holdings after the transaction were 25447.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SEVP, CHAIR
JNJJOHNSON & JOHNSON
Filing timeSep 04
Trade dateSep 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$278.43
Pre-filing
1mo ago -8.6%1w ago -3.0%1d ago -2.6%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

JNJ price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
JNJ since 2026-09-04Filed today · pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000200406-26-000179
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 04, 2026, 01:08 PM · 2d delay
Shares
22.5k sh
$27.4k per share
Estimated value
-$618M
Computed from shares × price
Holdings after
25.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Reduction Large Sale Repeat Seller
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP, WW Chair, MedTech

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).

  2. F2

    Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (8/31/2026).

  3. F3

    Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.

Original filing · 0000200406-26-000179
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

JNJ